132 related articles for article (PubMed ID: 17178165)
1. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
Maubach G; Lim MC; Kumar S; Zhuo L
Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
[TBL] [Abstract][Full Text] [Related]
2. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
3. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma increases cathepsin H mRNA levels in mouse macrophages.
Lafuse WP; Brown D; Castle L; Zwilling BS
J Leukoc Biol; 1995 Apr; 57(4):663-9. PubMed ID: 7722423
[TBL] [Abstract][Full Text] [Related]
6. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
Lee PT; Holt PG; McWilliam AS
Eur J Immunol; 2001 Aug; 31(8):2347-56. PubMed ID: 11477547
[TBL] [Abstract][Full Text] [Related]
7. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
8. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.
Wiendl H; Lautwein A; Mitsdörffer M; Krause S; Erfurth S; Wienhold W; Morgalla M; Weber E; Overkleeft HS; Lochmüller H; Melms A; Tolosa E; Driessen C
J Neuroimmunol; 2003 May; 138(1-2):132-43. PubMed ID: 12742663
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha.
Lüder CG; Walter W; Beuerle B; Maeurer MJ; Gross U
Eur J Immunol; 2001 May; 31(5):1475-84. PubMed ID: 11465104
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
[TBL] [Abstract][Full Text] [Related]
11. Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S.
Gresser O; Weber E; Hellwig A; Riese S; Régnier-Vigouroux A
Eur J Immunol; 2001 Jun; 31(6):1813-24. PubMed ID: 11433378
[TBL] [Abstract][Full Text] [Related]
12. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
[TBL] [Abstract][Full Text] [Related]
13. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
14. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
15. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.
Romieu-Mourez R; François M; Boivin MN; Stagg J; Galipeau J
J Immunol; 2007 Aug; 179(3):1549-58. PubMed ID: 17641021
[TBL] [Abstract][Full Text] [Related]
16. MHC class II expression in human basophils: induction and lack of functional significance.
Voskamp AL; Prickett SR; Mackay F; Rolland JM; O'Hehir RE
PLoS One; 2013; 8(12):e81777. PubMed ID: 24349126
[TBL] [Abstract][Full Text] [Related]
17. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines.
Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ
Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094
[TBL] [Abstract][Full Text] [Related]
18. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic stellate cells do not exhibit features of antigen-presenting cells.
Shimizu K; Hashimoto K; Tahara J; Imaeda H; Andoh A; Shiratori K
Pancreas; 2012 Apr; 41(3):422-7. PubMed ID: 22415667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
